User profiles for Katharina Hopp
Katharina Hopp, PhDUniversity of Colorado, Division of Renal Diseases & Hypertension Verified email at cuanschutz.edu Cited by 3745 |
[PDF][PDF] Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease
…, EK Dillinger, CM Heyer, K Hopp… - The American Journal of …, 2016 - cell.com
Autosomal-dominant polycystic kidney disease (ADPKD) is a common, progressive, adult-onset
disease that is an important cause of end-stage renal disease (ESRD), which requires …
disease that is an important cause of end-stage renal disease (ESRD), which requires …
[HTML][HTML] Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations to PKD1 or
PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease …
PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease …
[HTML][HTML] Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease
S Rossetti, VJ Kubly, MB Consugar, K Hopp, S Roy… - Kidney international, 2009 - Elsevier
Autosomal dominant polycystic kidney disease (ADPKD) caused by mutations in PKD1 is
significantly more severe than PKD2. Typically, ADPKD presents in adulthood but is rarely …
significantly more severe than PKD2. Typically, ADPKD presents in adulthood but is rarely …
[PDF][PDF] Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease
…, VG Gainullin, JM Smith, MP Audrézet, K Hopp… - The American Journal of …, 2018 - cell.com
Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by the progressive
development of kidney cysts, often resulting in end-stage renal disease (ESRD). This …
development of kidney cysts, often resulting in end-stage renal disease (ESRD). This …
Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria
Primary hyperoxaluria (PH) is a rare autosomal recessive disease characterized by oxalate
accumulation in the kidneys and other organs. Three loci have been identified: AGXT (PH1), …
accumulation in the kidneys and other organs. Three loci have been identified: AGXT (PH1), …
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing
S Rossetti, K Hopp, RA Sikkink… - Journal of the …, 2012 - journals.lww.com
Mutations in two large multi-exon genes, PKD1 and PKD2, cause autosomal dominant polycystic
kidney disease (ADPKD). The duplication of PKD1 exons 1–32 as six pseudogenes on …
kidney disease (ADPKD). The duplication of PKD1 exons 1–32 as six pseudogenes on …
Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD
Autosomal dominant polycystic kidney disease (ADPKD), caused by mutation in PKD1 or
PKD2, is usually an adult-onset disorder but can rarely manifest as a neonatal disease within a …
PKD2, is usually an adult-onset disorder but can rarely manifest as a neonatal disease within a …
Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) often results in ESRD but with a
highly variable course. Mutations to PKD1 or PKD2 cause ADPKD; both loci have high levels of …
highly variable course. Mutations to PKD1 or PKD2 cause ADPKD; both loci have high levels of …
Food restriction ameliorates the development of polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized
by the accumulation of kidney cysts that ultimately leads to loss of renal function and kidney …
by the accumulation of kidney cysts that ultimately leads to loss of renal function and kidney …
[HTML][HTML] Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited nephropathy
responsible for 4%–10% of end-stage renal disease cases. Mutations in the genes …
responsible for 4%–10% of end-stage renal disease cases. Mutations in the genes …